Stay updated on T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.

Latest updates to the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page
- Check4 days agoChange DetectedThe site now displays the Gurgaon, India research location name without the diacritic and updates the page’s revision/build version indicator.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoChange DetectedPadova, Italy, 35128 was added as a trial location and Padua, Italy, 35128 was removed. This aligns the location listing with the local naming convention to ensure accurate site identification.SummaryDifference0.0%

- Check25 days agoChange DetectedPublications section updated: added the 2026 NEJM article 'Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer' and removed the 2025 online-ahead-of-print citation.SummaryDifference0.0%

- Check33 days agoChange DetectedReplaced Gurgaon with Gūrgaon and Napoli with Naples in the study locations.SummaryDifference0.0%

- Check40 days agoChange DetectedCorrected the site entry from Gūrgaon, India, 122001 to Gurgaon, India, 122001. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.